Polyanionic carbohydrate doxorubicin–dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations
Parisa Yousefpour1,2, Fatemeh Atyabi1, Ebrahim Vashegani Farahani3, Ramin Sakhtianchi1, Rassoul Dinarvand11Nanotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; 2Department of Biotechnology, Faculty of Science, University of Tehran, Tehran, Iran 3D...
Guardado en:
Autores principales: | Yousefpour P, Atyabi F, Vasheghani Farahani E, Sakhtianchi R, Dinarv, R |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e5e8045cea994c61ae9ff02e0e8a0752 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab
por: Yousefpour P, et al.
Publicado: (2011) -
Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study
por: Ostad SN, et al.
Publicado: (2012) -
Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
por: Rouhani H, et al.
Publicado: (2011) -
The synergistic effect and mechanism of doxorubicin-ZnO nanocomplexes as a multimodal agent integrating diverse anticancer therapeutics
por: Deng Y, et al.
Publicado: (2013) -
Evaluation of atherosclerotic lesions using dextran- and mannan–dextran-coated USPIO: MRI analysis and pathological findings
por: Mukaisho K, et al.
Publicado: (2012)